Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer? ; volume:13 ; number:1 ; day:20 ; month:3 ; year:2018 ; pages:1-9 ; date:12.2018
Diagnostic pathology ; 13, Heft 1 (20.3.2018), 1-9, 12.2018
- Urheber
-
Eriksen, Ann C.
- Beteiligte Personen und Organisationen
-
Andersen, Johnnie B.
Lindebjerg, Jan
dePont Christensen, René
Hansen, Torben F.
Kjær-Frifeldt, Sanne
Sørensen, Flemming B.
SpringerLink (Online service)
- DOI
-
10.1186/s13000-018-0697-9
- URN
-
urn:nbn:de:1111-2018052026811
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eriksen, Ann C.
- Andersen, Johnnie B.
- Lindebjerg, Jan
- dePont Christensen, René
- Hansen, Torben F.
- Kjær-Frifeldt, Sanne
- Sørensen, Flemming B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Bioinformatics pipeline for revealing tumour heterogeneity: Bioinformatics pipeline for revealing tumour heterogeneity from single cells
Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
Histone variants: critical determinants in tumour heterogeneity
The role of integrins in TGFβ activation in the tumour stroma
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Bioinformatics pipeline for revealing tumour heterogeneity: Bioinformatics pipeline for revealing tumour heterogeneity from single cells
Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
Histone variants: critical determinants in tumour heterogeneity
The role of integrins in TGFβ activation in the tumour stroma
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Bioinformatics pipeline for revealing tumour heterogeneity: Bioinformatics pipeline for revealing tumour heterogeneity from single cells
Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
Histone variants: critical determinants in tumour heterogeneity
The role of integrins in TGFβ activation in the tumour stroma
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes